🇧🇷 Unloxcyt in Brazil

Unloxcyt (COSIBELIMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Unloxcyt in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Unloxcyt approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Unloxcyt in Brazil?

Checkpoint Therapeutics Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.